India Introduces a 7-Minute Cancer Injection: What it Costs, What it Offers, What the Risks Are, and Who Can Have It
Author: Dr Sagar Rajkuwar, ENT Specialist, Nashik, Maharashtra, India
🌐 www.entspecialistinnashik.com
With the introduction of a novel 7-minute immunotherapy injection for lung cancer patients, India has made significant progress in the treatment of advanced cancers. The therapy, which was launched by Roche Pharma India, seeks to expedite cancer treatment and make it less physically demanding and more practical for qualifying individuals.
The novel formulation, known as Tecentriq (atezolizumab), is intended to be given subcutaneously in around seven minutes, which is a significant improvement over the length of time required for conventional intravenous (IV) immunotherapy procedures. The treatment’s hefty price of about ₹3.7 lakh per dose, though, has also sparked concerns about affordability, despite the enthusiasm surrounding the introduction.
In this article, we discuss the mechanism of action of the novel cancer treatment, the criteria for patient selection, the advantages and hazards, the financial considerations, and the opinions of professionals.
Table of Contents
- What’s the New Cancer Injection that Only Takes 7 Minutes?
- What mechanism does this cancer shot employ?
- What makes the 7-minute procedure significant?
- Who is eligible for this procedure?
- The Biggest Worry: Cost
Does This Treat Cancer? - Immunotherapy’s Potential Adverse Effects
- Closing Remarks
- ❓ FAQ – India’s 7-Minute Cancer Injection (Tecentriq)
What’s the New Cancer Injection that Only Takes 7 Minutes?
The treatment, which has just been released, is a subcutaneous immunotherapy injection, which is administered beneath the skin as opposed to via an IV drip.
Ateolizumab, the active component of the drug, is a member of the class of drugs known as immune checkpoint inhibitors. These therapies improve the immune system’s ability to identify and destroy cancer cells.
Unlike chemotherapy, which kills cancer cells directly and may also harm healthy ones, immunotherapy uses a different strategy: it strengthens the body’s own defense system to fight cancer.
The injection has been made available to patients with non-small cell lung cancer (NSCLC), which is one of the most prevalent types of lung cancer in India. According to reports, this newer injection method has the potential to significantly shorten the duration of hospital care while enhancing patient well-being.
What mechanism does this cancer shot employ?
A protein known as PD-L1 is frequently used by cancer cells to evade the body’s immune system.
Atezolizumab, the medication found in Tecentriq, inhibits this protein. Immune cells are better able to recognize and kill cancer cells once they are blocked.
The therapy, in its simplest form, eliminates the “shield” that cancer cells use to evade the body’s innate defenses.
But this therapy does not affect everyone in the same way. To ascertain whether a patient is likely to benefit from the treatment, doctors typically advise PD-L1 testing. Patients with higher levels of PD-L1 typically have a better response to treatment.
What makes the 7-minute procedure significant?
One of the key benefits of the new injection is that it is convenient and saves time.
In the past, patients undergoing immunotherapy frequently had IV infusions at hospitals or cancer centers, which took many hours. The administration time for the novel injection is about seven minutes.
- Major benefits include:
- Fewer trips to the hospital
- Patients experience less physical fatigue
- Shorter wait times
- Increased comfort for older patients
- Greater adherence to therapy
- Less strain on hospitals
This can significantly improve the quality of life for those who must travel great distances in order to receive cancer therapy.
Doctors think that shortening the course of treatment may also help patients maintain therapy more consistently, particularly those who are daunted by numerous hospital visits.
Who is eligible for this procedure?
At the moment, the therapy is only authorized for use in certain individuals with non-small cell lung cancer (NSCLC).
But not everyone with lung cancer is eligible.
Doctors often examine:
- Kind and stage of cancer
- the amount of the PD-L1 protein
- general state of health
- Prior response to therapy
The medication may be used alone in some instances, or it may be used in conjunction with chemotherapy or other cancer therapies.
Before even thinking about immunotherapy, it’s critical to get a medical consultation for this reason.
The Biggest Worry: Cost
Although the procedure is convenient, cost is still a major issue.
According to reports, each dose costs about 3.7 lakh rupees, and some patients may need several doses during treatment.
The cost of therapy can sometimes reach lakhs or crores, which puts a lot of financial strain on families.
Immunotherapy treatments are often costly due to the significant research, development, and cutting-edge technology used to manufacture them.
According to reports, Roche has implemented a patient assistance program to increase access, and the therapy may be accessible through several reimbursement plans, including some that are supported by government healthcare aid systems. However, many middle-class families continue to have restricted access.
Does This Treat Cancer?
One of the greatest misconceptions is this.
Cancer cannot be treated with the new injection.
Rather, it’s a possible course of action that might be helpful:
- The gradual course of cancer
- Increase survival rates in individuals who qualify.
- lessen symptoms
- Improve one’s quality of life
Immunotherapy’s effects differ from patient to patient. Some patients experience significant improvements, while others may not see much change.
Cancer treatment should always be customized to the patient’s medical state, according to medical professionals.
Immunotherapy’s Potential Adverse Effects
Despite the common perception that immunotherapy is less harmful than chemotherapy, adverse effects can still occur.
Potential adverse consequences may include:
- Exhaustion
- High temperature
- Skin eruptions
- Respiratory difficulties
- Diarrhea
Inflammation in organs caused by the immune system
Treatment must always be administered under medical supervision.
Closing Remarks
A significant step forward in contemporary cancer treatment is the introduction of India’s seven-minute cancer injection. It may make many lung cancer patients feel more comfortable and at ease since it can shorten treatment times from hours to minutes.
After a medical examination and approval from an oncologist, the therapy is only appropriate for certain individuals, and cost remains a significant barrier.
Although this breakthrough is encouraging, experts caution patients and families not to see it as a miracle cure but as one possible therapy choice.
Disclaimer: This article is intended solely for informational purposes and should not be taken as medical guidance. Before deciding on a course of therapy, always seek the advice of a skilled oncologist or other medical professional.
❓ FAQ – India’s 7-Minute Cancer Injection (Tecentriq)
Q1. What is the new 7-minute cancer injection introduced in India?
The new treatment is a subcutaneous immunotherapy injection called Tecentriq containing atezolizumab, used mainly for certain lung cancer patients.
Q2. How does the 7-minute cancer injection work?
The injection blocks the PD-L1 protein that helps cancer cells hide from the immune system, allowing immune cells to attack cancer more effectively.
Q3. Which cancer patients can receive this injection?
The therapy is mainly approved for selected patients with non-small cell lung cancer (NSCLC) after evaluation by an oncologist.
Q4. Is the 7-minute cancer injection a cure for cancer?
❌ No. The treatment is not considered a complete cure but may help slow cancer progression, improve survival, and reduce symptoms in some patients.
Q5. What are the benefits of the new cancer injection?
Possible benefits include:
- Faster treatment time
- Fewer hospital visits
- Improved patient comfort
- Reduced treatment fatigue
- Better treatment convenience
Q6. How long does the injection take?
The subcutaneous injection usually takes around 7 minutes compared to longer IV infusion sessions.
Q7. What is the cost of the 7-minute cancer injection in India?
Reports suggest the cost may be approximately ₹3.7 lakh per dose, depending on treatment plans and hospital charges.
Q8. What are the side effects of immunotherapy injections?
Possible side effects may include:
- Fatigue
- Fever
- Skin rash
- Breathing difficulty
- Diarrhea
- Immune-related inflammation
Q9. Why is PD-L1 testing important before treatment?
PD-L1 testing helps doctors determine whether a patient is more likely to benefit from immunotherapy treatment.
Q10. Is immunotherapy safer than chemotherapy?
Immunotherapy may cause fewer traditional chemotherapy side effects in some patients, but it still carries serious risks and requires close medical supervision.
Q11. Can the injection be combined with chemotherapy?
✔️ Yes. In some cases, doctors may combine immunotherapy with chemotherapy or other cancer treatments.
Q12. Is this cancer treatment available across India?
Availability may vary depending on hospital infrastructure, oncology centers, and access programs.
Why is the 7-Minute Cancer Injection Significant?
Typically, cancer patients have numerous hospital trips throughout their treatment. Long infusions can be quite exhausting, both physically and mentally. The seven-minute cancer injection has the potential to improve a patient’s quality of life.
The benefits of a 7-minute cancer injection are as follows:
Less Treatment Time
Many hours of intravenous infusion sessions will not be necessary. The entire process takes less time.
Enhanced Comfort
Injection therapy may be more comfortable than infusion therapy for subcutaneous cancers.
Improved Efficiency
Treatment time reduction can improve hospitals’ ability to manage patients.
Enhancing Quality of Life
After receiving the injectable immunotherapy India therapy, patients will be able to resume their regular lives more quickly.
This therapy is effective against what kinds of cancer?
Despite the rising popularity of the 7-minute cancer injection in the treatment of lung cancer, there are a number of other cancer types that may benefit from the application of immunotherapy depending on the medical circumstances of the patients.
The following are some cancers that may benefit:
• Cancer of the lungs
• Melanoma
• Breast cancer
• Cancer of the bladder
• Cancer of the kidneys
• Cancer of the head and neck
A patient’s eligibility for the lung cancer injection India treatment is determined by a number of medical factors.
Which patients are eligible for the seven-minute cancer injection?
This cancer treatment may not be available to everyone. Prior to making a recommendation for the cancer immunotherapy injection, a number of variables will be taken into account.
Among the prerequisites for the cancer injection are:
• People who have been diagnosed with particular forms of lung cancer
• Patients who meet the criteria for immunotherapy therapy
• Some biomarker test results
• The capacity to withstand immunotherapy medications
• Those looking for quick treatment methods
Before beginning the cancer immunotherapy injection, patients may have imaging, blood, and pathology studies done.
Can Cancer Be Treated Safely with a 7-Minute Injection?
One of the primary considerations while receiving cancer treatment is safety. Before a therapy approach is implemented in hospitals, it undergoes clinical trials and medical research.
The 7-minute cancer injection, like other immunotherapy treatments, has the potential to have negative side effects in some individuals. The following are some typical side effects:
• tiredness
• swelling at the injection site
• Fever
• Cutaneous responses
• Body pain
• Coughing and breathlessness
India’s 7-Minute Cancer Injection Availability
In India, several of the greatest cancer facilities are seeing a slow but steady rise in the availability of modern cancer injection treatments. Modern treatment approaches, such as immunotherapy, are now being employed at major hospitals with specialized oncology units.
India offers lung cancer injections administered by professionals who are skilled at using immunotherapy to treat the illness.
Continental Hospitals offers a variety of cancer treatment options that includes a team of medical oncologists, radiation oncologists, surgical oncologists, pulmonologists, pathologists, and critical care experts.
What are the reasons for selecting Continental Hospitals for cancer therapy?
For successful cancer therapy, selecting the right hospital is crucial. Continental Hospitals are renowned for providing cutting-edge cancer therapies that adhere to global guidelines and utilize the most up-to-date technology.
Major Aspects of Continental Hospitals
• A comprehensive approach to cancer diagnosis and treatment
• Professional oncologists for different cancers
• Access to cutting-edge immunotherapy and targeted therapy
• Modern pathology and diagnostic imaging services
• A unique treatment approach for each patient
• Tumor board discussion involving multidisciplinary teams
• Prioritizing the needs of the patient during treatment and rehabilitation
International Standards: Accreditation and Excellence
Continental Hospitals is well-known for its dedication to providing high-quality treatment, including patient safety and medical proficiency. The hospital has accreditations from NABH and JCI, among others, demonstrating the international standardization of healthcare.
The following are among the accreditations:
- • Global quality standards
- • Promote improved infection control procedures
- • High requirements for patient safety
- • Treatment guidelines supported by evidence
- • Actions to improve the quality of healthcare
As a result, Continental Hospitals is among the top facilities in Hyderabad for offering cutting-edge immunotherapy and cancer therapies.
